Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.

@article{Mondal2013TumorGI,
  title={Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.},
  author={Goutam Mondal and Sugata Barui and Soumen Saha and Arabinda Chaudhuri},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  year={2013},
  volume={172 3},
  pages={832-40}
}
Increasing number of Phase I/II clinical studies have demonstrated clinical potential of curcumin for treatment of various types of human cancers. Despite significant anti-tumor efficacies and bio-safety profiles of curcumin, poor systemic bioavailability is retarding its clinical success. Efforts are now being directed toward developing stable formulations of curcumin using various drug delivery systems. To this end, herein we report on the development of a new tumor vasculature targeting… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…